CD4 and neoplasm: Among adaptive immune cells, Th2 cells, CD4+ T helper cells expressing Type 2 cytokines [e.g. interleukin (IL) 4, IL10], have been shown to promote tumor progression via activation of humoral immunity and inflammation (Shurin et al., 1999).